Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENHYZA: Hypnosis for Pain During Qutenza Patch Application
NCT02822625Phase 3Completed
- Sponsor
- Institut de Cancérologie de Lorraine
- Start
- Aug 2016
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Peripheral neuropathic pain, sponsored by Institut de Cancérologie de Lorraine. Primary endpoint: Pain induced by patch Qutenza at 1 day. Started Aug 2016; status: completed.
02
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT02822625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02822625.